CARDIOVASCULAR AGENT

Brand Owner (click to sort) Address Description
CLINIUM MENEIL LABORATORIES, INCORPORATED FORT WASHINGTON PA CARDIOVASCULAR AGENT;
CLOTLYSER Global Biotech Inc. Taipei Hsien 221 Taiwan Cardiovascular agent, namely, a human tissue plasminogen activator compound used to dissolve human blood clots;
ECOKINASE ROEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION 101 Orchard Ridge Drive Gaithersburg MD 20878 cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
ISORDIL BAUSCH HEALTH IRELAND LIMITED City West Business Campus 3013 Lake Drive Dublin 24 Ireland CARDIOVASCULAR AGENT;
LYCOR Boehringer Mannheim Pharmaceuticals Corporation 15204 Omega Drive Rockville MD 20850 cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
RAPILYSIN Boehringer Mannheim Pharmaceuticals Corporation 15204 Omega Drive Rockville MD 20850 cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infraction;RAPILY SIN;
RAPIVASE Boehringer Mannheim Pharmaceuticals Corporation 15204 Omega Drive Rockville MD 20850 cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
RETAVASE Boehringer Mannheim Pharmaceuticals Corporation 15204 Omega Drive Rockville MD 20850 cardiovascular agent, namely a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
RETAVASE EKR THERAPEUTICS, INC. 7 East Frederick Place Cedar Knolls NJ 07927 cardiovascular agent, namely, a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
RETAVASE CENTOCOR INCORPORATED 200 GREAT VALLEY PARKWAY MALVERN PA 19355 cardiovascular agent, namely, a recombinant plasminogen activator compound, for use in the management of acute myocardial infarction;
SUREXIN MCNEIL LABORATORIES, INCORPORATED PHILADELPHIA, PA. CARDIOVASCULAR AGENT;
VISKEN NOVARTIS AG CH-4002 Basel 4002 Switzerland CARDIOVASCULAR AGENT;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A system, method, and computer executable code for generating a likelihood of cardiovascular disease from acquired cardiovascular sound signals is diesclosed, where the generated likelihood of cardiovascular disease is based at least on an overlapping in time of bruit candidates in one heart cycle or in different heart cycles. Also disclosed is a system, method, and computer executable code for collecting, forwarding, and analyzing cardiovascular sound signals, where the collecting and analyzing may occur at locations that are remote from each other. Further disclosed is a system, method, and computer executable code for determining the time and phase information contained in cardiovascular sound signals, for use in analyzing those cardiovascular sound signals.